You just read:

Janssen Receives Two U.S. FDA Approvals For SIMPONI ARIA® (golimumab) For The Treatment Of Adults With Active Psoriatic Arthritis Or Active Ankylosing Spondylitis

News provided by

Janssen Biotech, Inc. (Janssen)

Oct 20, 2017, 16:23 ET